{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T16:56:00Z","timestamp":1648659360273},"reference-count":23,"publisher":"Oxford University Press (OUP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mod Rheumatol"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1007\/s10165-011-0570-0","type":"journal-article","created":{"date-parts":[[2011,12,13]],"date-time":"2011-12-13T09:19:41Z","timestamp":1323767981000},"page":"778-782","source":"Crossref","is-referenced-by-count":0,"title":["Development of anti-neutrophil cytoplasmic antibody-associated vasculitis in a patient with Graves\u2019 disease independent of anti-thyroid drug therapy"],"prefix":"10.1093","volume":"22","author":[{"given":"Nasim Ahmed","family":"Khan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manisha","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2011,12,14]]},"reference":[{"issue":"3","key":"570_CR1","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/MNH.0b013e3283456731","volume":"20","author":"JC Jennette","year":"2011","unstructured":"Jennette JC, Falk RJ, Gasim AH. Pathogenesis of antineutrophil cytoplasmic autoantibody vasculitis. Curr Opin Nephrol Hypertens. 2011;20(3):263\u201370.","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"6","key":"570_CR2","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1210\/er.2002-0020","volume":"24","author":"BS Prabhakar","year":"2003","unstructured":"Prabhakar BS, Bahn RS, Smith TJ. Current perspective on the pathogenesis of Graves\u2019 disease and ophthalmopathy. Endocr Rev. 2003;24(6):802\u201335.","journal-title":"Endocr Rev"},{"issue":"8872","key":"570_CR3","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/0140-6736(93)91761-A","volume":"342","author":"KM Dolman","year":"1993","unstructured":"Dolman KM, Gans RO, Vervaat TJ, et al. Vasculitis and antineutrophil cytoplasmic autoantibodies associated with propylthiouracil therapy. Lancet. 1993;342(8872):651\u20132.","journal-title":"Lancet"},{"issue":"5","key":"570_CR4","first-page":"336","volume":"47","author":"T Kitahara","year":"1997","unstructured":"Kitahara T, Hiromura K, Maezawa A, et al. Case of propylthiouracil-induced vasculitis associated with anti-neutrophil cytoplasmic antibody (ANCA): review of literature. Clin Nephrol. 1997;47(5):336\u201340.","journal-title":"Clin Nephrol"},{"issue":"5","key":"570_CR5","doi-asserted-by":"crossref","first-page":"R1072","DOI":"10.1186\/ar1789","volume":"7","author":"B Bonaci-Nikolic","year":"2005","unstructured":"Bonaci-Nikolic B, Nikolic MM, Andrejevic S, Zoric S, Bukilica M. Antineutrophil cytoplasmic antibody (ANCA)-associated autoimmune diseases induced by antithyroid drugs: comparison with idiopathic ANCA vasculitides. Arthritis Res Ther. 2005;7(5):R1072\u201381.","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"570_CR6","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/art.20927","volume":"53","author":"MC Slot","year":"2005","unstructured":"Slot MC, Links TP, Stegeman CA, Tervaert JW. Occurrence of antineutrophil cytoplasmic antibodies and associated vasculitis in patients with hyperthyroidism treated with antithyroid drugs: A long-term followup study. Arthritis Rheum. 2005;53(1):108\u201313.","journal-title":"Arthritis Rheum"},{"issue":"3","key":"570_CR7","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1046\/j.1365-2265.2001.01347.x","volume":"55","author":"IB Pedersen","year":"2001","unstructured":"Pedersen IB, Knudsen N, Perrild H, Ovesen L, Laurberg P. TSH-receptor antibody measurement for differentiation of hyperthyroidism into Graves\u2019 disease and multinodular toxic goitre: a comparison of two competitive binding assays. Clin Endocrinol (Oxf). 2001;55(3):381\u201390.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"570_CR8","first-page":"146","volume":"12","author":"A Aleksic","year":"2009","unstructured":"Aleksic A, Aleksic Z, Stojanovic M. TSH receptor antibodies for confirming the diagnosis and prediction of remission duration, in newly diagnosed Graves\u2019 disease patients. Hell J Nucl Med. 2009;12(2):146\u201350.","journal-title":"Hell J Nucl Med"},{"issue":"10","key":"570_CR9","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/j.1600-0560.2006.00699.x","volume":"34","author":"NI Comfere","year":"2007","unstructured":"Comfere NI, Macaron NC, Gibson LE. Cutaneous manifestations of Wegener\u2019s granulomatosis: a clinicopathologic study of 17 patients and correlation to antineutrophil cytoplasmic antibody status. J Cutan Pathol. 2007;34(10):739\u201347.","journal-title":"J Cutan Pathol"},{"issue":"1","key":"570_CR10","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.amjmed.2004.02.030","volume":"117","author":"P Seo","year":"2004","unstructured":"Seo P, Stone JH. The antineutrophil cytoplasmic antibody-associated vasculitides. Am J Med. 2004;117(1):39\u201350.","journal-title":"Am J Med"},{"issue":"5","key":"570_CR11","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1210\/jc.2002-021383","volume":"88","author":"M Guma","year":"2003","unstructured":"Guma M, Salinas I, Reverter JL, et al. Frequency of antineutrophil cytoplasmic antibody in Graves\u2019 disease patients treated with methimazole. J Clin Endocrinol Metab. 2003;88(5):2141\u20136.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"570_CR12","first-page":"949","volume":"14","author":"DT Noritake","year":"1987","unstructured":"Noritake DT, Weiner SR, Bassett LW, Paulus HE, Weisbart R. Rheumatic manifestations of Wegener\u2019s granulomatosis. J Rheumatol. 1987;14(5):949\u201351.","journal-title":"J Rheumatol"},{"issue":"9","key":"570_CR13","doi-asserted-by":"crossref","first-page":"611","DOI":"10.7326\/0003-4819-147-9-200711060-00005","volume":"147","author":"JD Finkielman","year":"2007","unstructured":"Finkielman JD, Merkel PA, Schroeder D, et al. Antiproteinase 3 antineutrophil cytoplasmic antibodies and disease activity in Wegener granulomatosis. Ann Intern Med. 2007;147(9):611\u20139.","journal-title":"Ann Intern Med"},{"issue":"4","key":"570_CR14","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1023\/A:1025642217482","volume":"34","author":"M Agraharkar","year":"2002","unstructured":"Agraharkar M, Gokhale S, Gupta R. Wegener\u2019s granulomatosis diagnosed by testicular biopsy. Int Urol Nephrol. 2002;34(4):559\u201364.","journal-title":"Int Urol Nephrol"},{"issue":"2","key":"570_CR15","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s12020-010-9373-x","volume":"38","author":"T Calhan","year":"2010","unstructured":"Calhan T, Senates E, Cebeci E, Zuhur SS, Ozbakir F, Gorpe U. A comparison of antineutrophil cytoplasmic antibody prevalence in patients treated and untreated for hyperthyroidism. Endocrine. 2010;38(2):199\u2013205.","journal-title":"Endocrine"},{"issue":"2","key":"570_CR16","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1742-1241.2006.01250.x","volume":"63","author":"MO Cin","year":"2009","unstructured":"Cin MO, Gursoy A, Morris Y, Aydintug OT, Kamel N, Gullu S. Prevalence and clinical significance of antineutrophil cytoplasmic antibody in Graves\u2019 patients treated with propylthiouracil. Int J Clin Pract. 2009;63(2):299\u2013302.","journal-title":"Int J Clin Pract"},{"issue":"5","key":"570_CR17","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1046\/j.1365-2265.2001.01282.x","volume":"54","author":"JY Noh","year":"2001","unstructured":"Noh JY, Asari T, Hamada N, et al. Frequency of appearance of myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA) in Graves\u2019 disease patients treated with propylthiouracil and the relationship between MPO-ANCA and clinical manifestations. Clin Endocrinol (Oxf). 2001;54(5):651\u20134.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"570_CR18","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1378\/chest.102.5.1595","volume":"102","author":"SJ Stankus","year":"1992","unstructured":"Stankus SJ, Johnson NT. Propylthiouracil-induced hypersensitivity vasculitis presenting as respiratory failure. Chest. 1992;102(5):1595\u20136.","journal-title":"Chest"},{"issue":"3","key":"570_CR19","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1007\/s10067-005-0165-2","volume":"26","author":"AJ Schuerwegh","year":"2007","unstructured":"Schuerwegh AJ, Verhelst J, Slabbynck H, Kockx MM, Coolen D. Wegener\u2019s granulomatosis presenting as a thyroid mass. Clin Rheumatol. 2007;26(3):454\u20136.","journal-title":"Clin Rheumatol"},{"issue":"12","key":"570_CR20","doi-asserted-by":"crossref","first-page":"3508","DOI":"10.1093\/ndt\/gfm493","volume":"22","author":"S Lionaki","year":"2007","unstructured":"Lionaki S, Hogan SL, Falk RJ, et al. Association between thyroid disease and its treatment with ANCA small-vessel vasculitis: a case\u2013control study. Nephrol Dial Transpl. 2007;22(12):3508\u201315.","journal-title":"Nephrol Dial Transpl"},{"issue":"8","key":"570_CR21","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1002\/art.11075","volume":"48","author":"JH Stone","year":"2003","unstructured":"Stone JH; Wegener\u2019s Granulomatosis Etanercept Trial Research Group. Limited versus severe Wegener\u2019s granulomatosis: baseline data on patients in the Wegener\u2019s granulomatosis etanercept trial. Arthritis Rheum. 2003;48(8):2299\u2013309.","journal-title":"Arthritis Rheum"},{"issue":"Suppl 1","key":"570_CR22","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1365-2249.2011.04362.x","volume":"164","author":"CO Savage","year":"2011","unstructured":"Savage CO. Pathogenesis of anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis. Clin Exp Immunol. 2011;164[Suppl 1]:23\u20136.","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"570_CR23","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1172\/JCI111663","volume":"75","author":"SA Weitzman","year":"1985","unstructured":"Weitzman SA, Stossel TP, Harmon DC, Daniels G, Maloof F, Ridgway EC. Antineutrophil autoantibodies in Graves\u2019 disease. Implications of thyrotropin binding to neutrophils. J Clin Invest. 1985;75(1):119\u201323.","journal-title":"J Clin Invest"}],"container-title":["Modern Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s10165-011-0570-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T16:25:30Z","timestamp":1646843130000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10165-011-0570-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,14]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["570"],"URL":"https:\/\/doi.org\/10.1007\/s10165-011-0570-0","relation":{},"ISSN":["1439-7595","1439-7609"],"issn-type":[{"value":"1439-7595","type":"print"},{"value":"1439-7609","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,14]]}}}